Improve Medical Instruments Co., Ltd. Share Price
Equities
300030
CNE100000JL3
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.43 CNY | 0.00% | +8.31% | -42.84% |
Sales 2021 | 800M 110M 9.21B | Sales 2022 | 711M 98.09M 8.18B | Capitalization | 2.13B 294M 24.52B |
---|---|---|---|---|---|
Net income 2021 | 18M 2.48M 207M | Net income 2022 | -198M -27.33M -2.28B | EV / Sales 2021 | 4.34 x |
Net Debt 2021 | 179M 24.72M 2.06B | Net Debt 2022 | 202M 27.91M 2.33B | EV / Sales 2022 | 3.28 x |
P/E ratio 2021 |
178
x | P/E ratio 2022 |
-10.8
x | Employees | 1,069 |
Yield 2021 |
0.38% | Yield 2022 |
-
| Free-Float | 60.22% |
1 week | +8.31% | ||
Current month | -20.04% | ||
1 month | -19.75% | ||
3 months | -36.26% | ||
6 months | -42.62% | ||
Current year | -42.84% |
Managers | Title | Age | Since |
---|---|---|---|
Guan Hua Deng
CEO | Chief Executive Officer | 58 | 26/07/26 |
Hong Yu Yan
DFI | Director of Finance/CFO | 60 | 22/10/22 |
Wei Yu
BRD | Director/Board Member | 38 | 31/21/31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | 12/17/12 | |
Guan Hua Deng
CEO | Chief Executive Officer | 58 | 26/07/26 |
Hong Yu Yan
DFI | Director of Finance/CFO | 60 | 22/10/22 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 4.43 | 0.00% | 11,251,640 |
25/24/25 | 4.43 | +1.61% | 6,623,100 |
24/24/24 | 4.36 | +5.06% | 8,550,271 |
23/24/23 | 4.15 | +4.80% | 9,077,200 |
22/24/22 | 3.96 | -3.18% | 9,442,500 |
End-of-day quote Shenzhen S.E., April 26, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-42.84% | 189M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+2.17% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- 300030 Stock